Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis
Top Cited Papers
- 22 February 2017
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (378)
Abstract
Commensal skin bacteria produce previously unknown antimicrobial peptides that can inhibit Staphylococcus aureus colonization of atopic dermatitis subjects.Keywords
Funding Information
- National Institutes of Health (award290992)
This publication has 63 references indexed in Scilit:
- Epithelial antimicrobial defence of the skin and intestineNature Reviews Immunology, 2012
- Antimicrobial Peptides: Old Molecules with New IdeasJournal of Investigative Dermatology, 2012
- A mass spectrometry–guided genome mining approach for natural product peptidogenomicsNature Chemical Biology, 2011
- Microbial Symbiosis with the Innate Immune Defense System of the SkinJournal of Investigative Dermatology, 2011
- Activation of TLR2 by a Small Molecule Produced by Staphylococcus epidermidis Increases Antimicrobial Defense against Bacterial Skin InfectionsJournal of Investigative Dermatology, 2010
- Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteriaProceedings of the National Academy of Sciences, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Selective Antimicrobial Action Is Provided by Phenol-Soluble Modulins Derived from Staphylococcus epidermidis, a Normal Resident of the SkinJournal of Investigative Dermatology, 2010
- Commensal bacteria regulate Toll-like receptor 3–dependent inflammation after skin injuryNature Medicine, 2009
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsJournal of Experimental Medicine, 2007